Wenbin Zheng
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta-analysis.
Journal: Diabetes, obesity & metabolism
Published: September 06, 2024
Glucose Parameters, Inflammation Markers, and Gut Microbiota Changes of Gut Microbiome-Targeted Therapies in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 20, 2024
Identification of circulating inflammation cytokines as a mediator of gut microbiota and type 2 diabetes mellitus: a Mendelian randomization study.
Journal: Diabetology & metabolic syndrome
Published: July 03, 2024
Individuals with cardiometabolic risk factors are at higher risk for early-onset NAFLD.
Journal: Journal of hepatology
Published: April 10, 2024
Uric acid may serve as the sixth cardiometabolic criterion for defining MASLD.
Journal: Journal of hepatology
Published: November 16, 2023
Changing from NAFLD to MASLD: The new definition can more accurately identify individuals at higher risk for diabetes.
Journal: Journal of hepatology
Published: September 26, 2023
High triglyceride glucose-body mass index correlates with prehypertension and hypertension in east Asian populations: A population-based retrospective study.
Journal: Frontiers in cardiovascular medicine
Published: January 07, 2023
J-shape relationship between normal fasting plasma glucose and risk of type 2 diabetes in the general population: results from two cohort studies.
Journal: Journal of translational medicine
Published: December 13, 2022
Association of four lipid-derived indicators with the risk of developing type 2 diabetes: a Chinese population-based cohort study.
Journal: Lipids in health and disease
Published: December 12, 2022
Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice.
Journal: International journal of endocrinology
Published: December 11, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026